FdaApplication

ANDA 091471

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMYLAN PHARMACEUTICALS INC
application_typeANDA
approval_date2016-02-17

Products (1)

ProductActive ingredientStrengthDosage form
EFAVIRENZEFAVIRENZ600MGTABLET;ORAL

1 product